Cargando…
Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis
BACKGROUND AND OBJECTIVES: Rituximab (RTX) is considered to be a promising drug for curing membranous nephropathy. However, the efficacy and safety of RTX in treating membranous nephropathy remain uncertain. This meta-analysis aimed to investigate the efficacy and safety of RTX in patients with memb...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440335/ https://www.ncbi.nlm.nih.gov/pubmed/32311997 http://dx.doi.org/10.1097/MD.0000000000019804 |